HR Execs on the Move

Lensar

www.lensar.com

 
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.lensar.com
  • 2800 Discovery Drive
    Orlando, FL USA 32826
  • Phone: 888.536.7271

Executives

Name Title Contact Details
Jesse Turner
 Vice President of Sales Profile
Kendra Wong
 Principal Accounting Officer Profile

Similar Companies

Healthline Medical

Healthline Medical is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

nechealth

nechealth is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.

Stago

Stago is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Advantis Medical

Advantis Medical is a Greenwood, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.